Loss of Smooth Muscle Tenascin-X Inhibits Vascular Remodeling Through Increased TGF-β Signaling

Arterioscler Thromb Vasc Biol. 2024 Aug;44(8):1748-1763. doi: 10.1161/ATVBAHA.123.321067. Epub 2024 Jun 27.

Abstract

Background: Vascular smooth muscle cells (VSMCs) are highly plastic. Vessel injury induces a phenotypic transformation from differentiated to dedifferentiated VSMCs, which involves reduced expression of contractile proteins and increased production of extracellular matrix and inflammatory cytokines. This transition plays an important role in several cardiovascular diseases such as atherosclerosis, hypertension, and aortic aneurysm. TGF-β (transforming growth factor-β) is critical for VSMC differentiation and to counterbalance the effect of dedifferentiating factors. However, the mechanisms controlling TGF-β activity and VSMC phenotypic regulation under in vivo conditions are poorly understood. The extracellular matrix protein TN-X (tenascin-X) has recently been shown to bind TGF-β and to prevent it from activating its receptor.

Methods: We studied the role of TN-X in VSMCs in various murine disease models using tamoxifen-inducible SMC-specific knockout and adeno-associated virus-mediated knockdown.

Results: In hypertensive and high-fat diet-fed mice, after carotid artery ligation as well as in human aneurysmal aortae, expression of Tnxb, the gene encoding TN-X, was increased in VSMCs. Mice with smooth muscle cell-specific loss of TN-X (SMC-Tnxb-KO) showed increased TGF-β signaling in VSMCs, as well as upregulated expression of VSMC differentiation marker genes during vascular remodeling compared with controls. SMC-specific TN-X deficiency decreased neointima formation after carotid artery ligation and reduced vessel wall thickening during Ang II (angiotensin II)-induced hypertension. SMC-Tnxb-KO mice lacking ApoE showed reduced atherosclerosis and Ang II-induced aneurysm formation under high-fat diet. Adeno-associated virus-mediated SMC-specific expression of short hairpin RNA against Tnxb showed similar beneficial effects. Treatment with an anti-TGF-β antibody or additional SMC-specific loss of the TGF-β receptor reverted the effects of SMC-specific TN-X deficiency.

Conclusions: In summary, TN-X critically regulates VSMC plasticity during vascular injury by inhibiting TGF-β signaling. Our data indicate that inhibition of vascular smooth muscle TN-X may represent a strategy to prevent and treat pathological vascular remodeling.

Keywords: aortic aneurysm; atherosclerosis; hypertension; muscle, smooth, vascular; neointima.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II
  • Animals
  • Aortic Aneurysm / genetics
  • Aortic Aneurysm / metabolism
  • Aortic Aneurysm / pathology
  • Aortic Aneurysm / prevention & control
  • Carotid Artery Injuries / genetics
  • Carotid Artery Injuries / metabolism
  • Carotid Artery Injuries / pathology
  • Cells, Cultured
  • Diet, High-Fat
  • Disease Models, Animal
  • Humans
  • Hypertension / genetics
  • Hypertension / metabolism
  • Hypertension / pathology
  • Hypertension / physiopathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Knockout, ApoE
  • Muscle, Smooth, Vascular* / metabolism
  • Muscle, Smooth, Vascular* / pathology
  • Myocytes, Smooth Muscle* / metabolism
  • Myocytes, Smooth Muscle* / pathology
  • Neointima
  • Phenotype
  • Signal Transduction*
  • Tenascin* / deficiency
  • Tenascin* / genetics
  • Tenascin* / metabolism
  • Transforming Growth Factor beta / metabolism
  • Vascular Remodeling*

Substances

  • Angiotensin II
  • Tenascin
  • Transforming Growth Factor beta
  • tenascin X